Fund Holdings — SUPERSTRING CAPITAL MANAGEMENT LP

Total Portfolio Value
$101.50M
Total Bought
$54.85M
Total Sold
$43.36M
Net Transaction
+$11.49M
Filing Period:
Securities
▲▼
SharesValue ($K)
Q2 2025
▲▼
Q3 2025
▲▼
Change
▲▼
Q2 2025
▲▼
Q3 2025
▲▼
Weight (%)
▲▼
Change
▲▼
CIDARA THERAPEUTICS INC068,463+68,46306,5566.46%+6,556
IMMUNOVANT INC(IMVT)0341,348+341,34805,5035.42%+5,503
SUMMIT THERAPEUTICS INC(SMMT)0197,253+197,25304,0754.01%+4,075
IQVIA HLDGS INC(IQV)019,114+19,11403,6313.58%+3,631
REGENERON PHARMACEUTICALS(REGN)06,401+6,40103,5993.55%+3,599
89BIO INC212,377384,652+172,2752,0865,6545.57%+3,569
BRIGHT MINDS BIOSCIENCES INC(DRUG)053,950+53,95003,2733.22%+3,273
NEKTAR THERAPEUTICS(NKTR)051,270+51,27002,9172.87%+2,917
AVALO THERAPEUTICS INC(AVTX)0188,080+188,08002,3902.36%+2,390
SANOFI SA(SNY)050,407+50,40702,3792.34%+2,379
SAVARA INC(SVRA)1,115,3791,309,236+193,8572,5434,6744.60%+2,131
ZAI LAB LTD(ZLAB)134,895200,628+65,7334,7176,7996.70%+2,082
CABALETTA BIO INC(CABA)1,060,7641,544,525+483,7611,6123,6143.56%+2,002
UNIQURE NV(QURE)033,175+33,17501,9361.91%+1,936
KEROS THERAPEUTICS INC(KROS)095,083+95,08301,5041.48%+1,504
SCHOLAR ROCK HLDG CORP(SRRK)039,521+39,52101,4721.45%+1,472
INSMED INC(INSM)14,57119,786+5,2151,4662,8492.81%+1,383
PROTAGONIST THERAPEUTICS INC020,358+20,35801,3521.33%+1,352
TERNS PHARMACEUTICALS INC1,286,681789,646-497,0354,7995,9305.84%+1,131
ZENAS BIOPHARMA INC(ZBIO)111,60596,665-14,9401,0812,1462.11%+1,065
BICARA THERAPEUTICS INC189,699175,902-13,7971,7622,7772.74%+1,015
VIR BIOTECHNOLOGY INC(VIR)0150,312+150,31208580.85%+858
CORBUS PHARMACEUTICALS HLDGS(CRBP)057,644+57,64407290.72%+729
JAZZ PHARMACEUTICALS PLC(JAZZ)44,10740,893-3,2144,6815,3905.31%+709
RAPT THERAPEUTICS INC26,03434,449+8,4152088880.88%+680
UROGEN PHARMA LTD(URGN)87,91287,91201,2041,7541.73%+549
I MAB(NBP)0139,886+139,88605290.52%+529
PROTARA THERAPEUTICS INC(TARA)360,000360,00001,0911,5661.54%+475
BRIDGEBIO PHARMA INC(BBIO)96,76688,658-8,1084,1784,6054.54%+427
TECTONIC THERAPEUTIC INC(TECX)79,058119,286+40,2281,5711,8721.84%+301
BIOMEA FUSION INC(BMEA)250,000250,00004505050.50%+55
CENTURY THERAPEUTICS INC(IPSC)462,963462,96302592310.23%-28
LAKESHORE BIOPHARMA CO LTD30,7920-30,792310—-31
SO YOUNG INTERNATIONAL INC(SY)72,9360-72,9362260—-226
KYVERNA THERAPEUTICS INC(KYTX)142,5420-142,5424380—-438
WAVE LIFE SCIENCES LTD(WVE)70,2420-70,2424570—-457
ROCKET PHARMACEUTICALS INC(RCKT)214,4120-214,4125250—-525
OCULAR THERAPEUTIX INC(OCUL)88,9800-88,9808260—-826
MOONLAKE IMMUNOTHERAPEUTICS(MLTX)17,6230-17,6238320—-832
LIQUIDIA CORPORATION(LQDA)71,0710-71,0718860—-886
AVIDITY BIOSCIENCES INC47,0370-47,0371,3360—-1,336
UNITED THERAPEUTICS CORP DEL(UTHR)4,8740-4,8741,4010—-1,401
COGENT BIOSCIENCES INC(COGT)962,951361,408-601,5436,9145,1905.11%-1,724
CYTOKINETICS INC(CYTK)61,1030-61,1032,0190—-2,019
ORIC PHARMACEUTICALS INC(ORIC)344,92289,346-255,5763,5011,0721.06%-2,429
TRAVERE THERAPEUTICS INC(TVTX)276,47453,627-222,8474,0921,2821.26%-2,810
SOLENO THERAPEUTICS INC33,6910-33,6912,8230—-2,823
IONIS PHARMACEUTICALS INC(IONS)98,2670-98,2673,8830—-3,883
ULTRAGENYX PHARMACEUTICAL IN(RARE)130,4220-130,4224,7420—-4,742
NEUROCRINE BIOSCIENCES INC(NBIX)40,6080-40,6085,1040—-5,104
VERONA PHARMA PLC68,9820-68,9826,5240—-6,524
Page 1 of 1
SUPERSTRING CAPITAL MANAGEMENT LP — 13F Holdings — Q3 2025 | TickerTrail